-
December 7: The Week in Cancer NewsA trial tests a new treatment for some patients with early-stage breast cancer, and studies assess how long the benefits of CAR-T cell therapy last for patients with non-Hodgkin lymphoma.
by Kate Yandell
-
November 30: The Week in Cancer NewsA study warns that popular YouTube videos about prostate cancer may be misleading, and the U.S. Food and Drug Administration approves a therapy based on tumor genetics, not tumor origin.
by Kate Yandell
-
November 16: The Week in Cancer NewsA study links adolescent obesity to adult pancreatic cancer risk, and “Batkid” turns 10 years old.
by Bradley Jones
-
November 9: The Week in Cancer NewsA study assesses how timing affects the outcomes of pregnancy after cancer treatment, and researchers present on the benefits of Medicaid expansion for breast cancer patients.
by Kate Yandell
-
November 2: The Week in Cancer NewsA survey shows that 39 percent of Americans believe that alternative therapies can cure cancer, and a trial finds that minimally invasive surgery is inferior to traditional surgery for treating cervical cancer.
by Kate Yandell
-
October 26: The Week in Cancer NewsResearchers present cancer clinical trial results at the ESMO 2018 Congress, and a study shows that crowdfunding campaigns are raising money for unproven cancer treatments.
by Kate Yandell
-
October 19: The Week in Cancer NewsA study investigates cancer care for rural children, and the U.S. Food and Drug Administration approves a new breast cancer therapy.
by Kate Yandell
-
October 12: The Week in Cancer NewsA study sheds light on the difficulty patients have in accessing their medical records, and the U.S. Food and Drug Administration expands approval of the human papillomavirus vaccine.
by Kate Yandell
-
October 5: The Week in Cancer NewsCancer immunology researchers are awarded a Nobel Prize, and a seventh immune checkpoint inhibitor is approved by the U.S. Food and Drug Administration.
by Kate Yandell
-
September 28: The Week in Cancer NewsA study characterizes “chemo brain” in breast cancer patients treated with chemotherapy, and physicians and scientists gather in Toronto to present their lung cancer research.
by Kate Yandell
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
